Ekso Bionics Holdings Inc. (EKSO) 4.05 $EKSO
Research and Markets - Global Wearable Robots & Exoskeleton Market Report 2016-2021 Featuring Ekso, Lockheed Martin, Sarcos / Raytheon, BAE Systems, Panasonic, Honda, Daewoo, Noonee, Revision Military, and Cyberdyne
PR Newswire - Fri Aug 19, 11:10AM CDT
Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Wearable Robots, Exoskeleton: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2021" to their offering.
RTN: 142.50 (-0.09), EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Closing of Public Offering of Common Stock
GlobeNewswire - Fri Aug 12, 10:00AM CDT
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the closing of its previously announced public offering of 3,750,000 shares of common stock, at a price to the public of $4.00 per share. The net proceeds to the Company are expected to be $13.7 million, after deducting underwriting discounts and offering expenses payable by the Company. The underwriters have been granted a 30-day option to purchase an additional 562,500 shares at the public offering price to cover over-allotments.
EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Uplisting to Nasdaq Capital Market and Pricing of $15 Million Offering of Common Stock
GlobeNewswire - Tue Aug 09, 8:01AM CDT
Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced approval to list its common stock on the Nasdaq Capital Market. The Company's common stock will begin trading under the symbol "EKSO" at the opening of trading on August 9, 2016.
EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Proposed Public Offering of Common Stock
GlobeNewswire - Mon Aug 08, 3:09PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of the offering, the Company also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or term of the offering.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) Reports Second Quarter 2016 Results
GlobeNewswire - Thu Jul 28, 3:03PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended June 30, 2016.
EKSO: 4.05 (-0.02)
A World Without Wheelchairs from Bionik Labs and EKSO and ReWalk
ACCESSWIRE - Thu Jul 28, 8:20AM CDT
NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bionics. Electronic life - mechanical systems that mimic the function of living organisms. Imagine a time when a paralyzed man can walk, when a mother with only one arm can clap at her daughter's recital. That time is now. Like no other in history, we are in an age where bionics will impact the lives of the disabled. Numbers in America alone are staggering: 300,000 suffer spinal cord injury each year with less than 1% fully recovered; 1 in 50 people are para- or quadriplegic costing upwards of $500,000 for care in just the first year; and victims of debilitating stroke, roughly 800,000 per year, cost our healthcare system $34 billion.
EKSO: 4.05 (-0.02)
EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology
Marketwire Canada - Tue Jun 07, 5:00AM CDT
With Vodafone Global IoT SIM, Ekso Bionics Manages Device Diagnostics and Data to Help Improve the Mobility of Stroke and Spinal Cord Injury Patients
EKSO: 4.05 (-0.02), VOD: 31.31 (-0.37)
Ekso Bionics Announces Inaugural Open House Event
GlobeNewswire - Thu Jun 02, 5:27PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that they will open their doors to the general public on the afternoon of Friday, June 10th, 2016. The open house will commence with a morning research preview for healthcare professionals, presented by thought leader Dr. Dylan Edwards. Dr. Edwards will share his preliminary findings on how using Ekso GT, the only exoskeleton cleared for stroke, is helping his patients relearn to walk. Afternoon activities include a unique opportunity to experience a range of exoskeleton technologies first hand, tour Ekso Bionics' historic Henry Ford factory facility and watch live exoskeleton demonstrations.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) Reports First Quarter 2016 Results
GlobeNewswire - Tue May 10, 4:08PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) (currently listed as OTCQB:EKSOD), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2016.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) To Showcase First FDA Cleared Exoskeleton Approved for Use with Stroke Patients at 9th World Congress for NeuroRehabilitation (WCNR)
GlobeNewswire - Tue May 10, 6:07AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSOD), a robotic exoskeleton company, today announced that it will be attending the 9 World Congress for NeuroRehabilitation (WCNR), taking place May 10-13, 2016 in Philadelphia, PA.
EKSO: 4.05 (-0.02)
Ekso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ
GlobeNewswire - Wed May 04, 3:31PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has effected a 1-for-7 reverse split of its common stock in preparation for its planned application for listing of its common stock on the NASDAQ Capital Market. The reverse stock split was approved by the company's board of directors and is intended to allow the company to meet the minimum share price requirement for listing on the NASDAQ Capital Market. The company believes that it currently meets all of the listing requirements for listing the company's common stock on the NASDAQ Capital Market other than the minimum trading price requirement. However, there is no assurance that the company's listing application will be approved by NASDAQ.
EKSO: 4.05 (-0.02)
SoldierStrong to Donate Ekso GT(TM) Robotic Exoskeleton for Use with Stroke and Spinal Cord Injury Patients
GlobeNewswire - Wed May 04, 6:02AM CDT
SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced that it will donate an Ekso GT(TM) exoskeleton to Magee Rehabilitation Hospital with a live demonstration on Wednesday, May 4, 2016 at noon. Former Magee patient Frank LaMacchia, who previously sustained a spinal cord injury, will stand up and walk above ground using the Ekso GT.
EKSO: 4.05 (-0.02)
Ekso Bionics to Report First Quarter 2016 Financial Results on May 10, 2016
GlobeNewswire - Wed Apr 27, 3:03PM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2016 after the close of trading on Tuesday, May 10, 2016. The Company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
EKSO: 4.05 (-0.02)
Buying Stocks: Investors Are Considering These on Thursday April 7
ACCESSWIRE - Thu Apr 07, 12:34PM CDT
MIAMI, FL / ACCESSWIRE / April 7, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. CANN, COOL, TTPH, and EKSO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
TTPH: 3.99 (-0.02), COOL: 3.66 (-0.08), EKSO: 4.05 (-0.02)
Bionik Acquires Synergistic, Commercial Stage Technology Portfolio
ACCESSWIRE - Mon Apr 04, 8:20AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 4, 2016 / Robotic exoskeletons have become increasingly popular in recent years. While Tony Stark popularized the concept on the big screen, several companies are diligently working to bring the technology to the real world for a number of different applications.
IBM: 160.04 (-1.32), EKSO: 4.05 (-0.02), RWLK: 6.20 (-0.05)
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
Globe Newswire - Mon Apr 04, 6:00AM CDT
RICHMOND, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with device's labeling. The Ekso GT is the first exoskeleton cleared by the FDA for use with stroke patients.
EKSO: 4.05 (-0.02)
Global Exoskeleton Robots Market 2016-2020 - Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics - Research and Markets
BusinessWire - Fri Mar 18, 8:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pz2qx6/global) has announced the addition of the "Global Exoskeleton Robots Market 2016-2020" report to their offering.
EKSO: 4.05 (-0.02), RWLK: 6.20 (-0.05)
Story Behind the Charts -- Featured Research on Progressive Care, Ekso Bionics, LVMH Moet Hennessy Louis Vuitton, and China Gold International Resources
ACCESSWIRE - Wed Mar 16, 6:55AM CDT
NEW YORK, NY / ACCESSWIRE / March 16, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Progressive Care Inc. (OTC: RXMD), Ekso Bionics Holdings Inc. (OTC: EKSO), LVMH Moet Hennessy Louis Vuitton SE (OTC: LVMUY) and China Gold International Resources Corp. Ltd. (OTC: JINFF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
EKSO: 4.05 (-0.02)
Research and Markets - Global Wearable Robots & Exoskeleton Market Report 2016-2021 Featuring Ekso, Lockheed Martin, Sarcos / Raytheon, BAE Systems, Panasonic, Honda, Daewoo, Noonee, Revision Military, and Cyberdyne
PR Newswire - Fri Aug 19, 11:10AM CDT
Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Wearable Robots, Exoskeleton: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2021" to their offering.
RTN: 142.50 (-0.09), EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Closing of Public Offering of Common Stock
GlobeNewswire - Fri Aug 12, 10:00AM CDT
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the closing of its previously announced public offering of 3,750,000 shares of common stock, at a price to the public of $4.00 per share. The net proceeds to the Company are expected to be $13.7 million, after deducting underwriting discounts and offering expenses payable by the Company. The underwriters have been granted a 30-day option to purchase an additional 562,500 shares at the public offering price to cover over-allotments.
EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Uplisting to Nasdaq Capital Market and Pricing of $15 Million Offering of Common Stock
GlobeNewswire - Tue Aug 09, 8:01AM CDT
Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced approval to list its common stock on the Nasdaq Capital Market. The Company's common stock will begin trading under the symbol "EKSO" at the opening of trading on August 9, 2016.
EKSO: 4.05 (-0.02)
Ekso Bionics Holdings Announces Proposed Public Offering of Common Stock
GlobeNewswire - Mon Aug 08, 3:09PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of the offering, the Company also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or term of the offering.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) Reports Second Quarter 2016 Results
GlobeNewswire - Thu Jul 28, 3:03PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended June 30, 2016.
EKSO: 4.05 (-0.02)
A World Without Wheelchairs from Bionik Labs and EKSO and ReWalk
ACCESSWIRE - Thu Jul 28, 8:20AM CDT
NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bionics. Electronic life - mechanical systems that mimic the function of living organisms. Imagine a time when a paralyzed man can walk, when a mother with only one arm can clap at her daughter's recital. That time is now. Like no other in history, we are in an age where bionics will impact the lives of the disabled. Numbers in America alone are staggering: 300,000 suffer spinal cord injury each year with less than 1% fully recovered; 1 in 50 people are para- or quadriplegic costing upwards of $500,000 for care in just the first year; and victims of debilitating stroke, roughly 800,000 per year, cost our healthcare system $34 billion.
EKSO: 4.05 (-0.02)
EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology
Marketwire Canada - Tue Jun 07, 5:00AM CDT
With Vodafone Global IoT SIM, Ekso Bionics Manages Device Diagnostics and Data to Help Improve the Mobility of Stroke and Spinal Cord Injury Patients
EKSO: 4.05 (-0.02), VOD: 31.31 (-0.37)
Ekso Bionics Announces Inaugural Open House Event
GlobeNewswire - Thu Jun 02, 5:27PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that they will open their doors to the general public on the afternoon of Friday, June 10th, 2016. The open house will commence with a morning research preview for healthcare professionals, presented by thought leader Dr. Dylan Edwards. Dr. Edwards will share his preliminary findings on how using Ekso GT, the only exoskeleton cleared for stroke, is helping his patients relearn to walk. Afternoon activities include a unique opportunity to experience a range of exoskeleton technologies first hand, tour Ekso Bionics' historic Henry Ford factory facility and watch live exoskeleton demonstrations.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) Reports First Quarter 2016 Results
GlobeNewswire - Tue May 10, 4:08PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) (currently listed as OTCQB:EKSOD), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2016.
EKSO: 4.05 (-0.02)
Ekso Bionics(R) To Showcase First FDA Cleared Exoskeleton Approved for Use with Stroke Patients at 9th World Congress for NeuroRehabilitation (WCNR)
GlobeNewswire - Tue May 10, 6:07AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSOD), a robotic exoskeleton company, today announced that it will be attending the 9 World Congress for NeuroRehabilitation (WCNR), taking place May 10-13, 2016 in Philadelphia, PA.
EKSO: 4.05 (-0.02)
Ekso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ
GlobeNewswire - Wed May 04, 3:31PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has effected a 1-for-7 reverse split of its common stock in preparation for its planned application for listing of its common stock on the NASDAQ Capital Market. The reverse stock split was approved by the company's board of directors and is intended to allow the company to meet the minimum share price requirement for listing on the NASDAQ Capital Market. The company believes that it currently meets all of the listing requirements for listing the company's common stock on the NASDAQ Capital Market other than the minimum trading price requirement. However, there is no assurance that the company's listing application will be approved by NASDAQ.
EKSO: 4.05 (-0.02)
SoldierStrong to Donate Ekso GT(TM) Robotic Exoskeleton for Use with Stroke and Spinal Cord Injury Patients
GlobeNewswire - Wed May 04, 6:02AM CDT
SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced that it will donate an Ekso GT(TM) exoskeleton to Magee Rehabilitation Hospital with a live demonstration on Wednesday, May 4, 2016 at noon. Former Magee patient Frank LaMacchia, who previously sustained a spinal cord injury, will stand up and walk above ground using the Ekso GT.
EKSO: 4.05 (-0.02)
Ekso Bionics to Report First Quarter 2016 Financial Results on May 10, 2016
GlobeNewswire - Wed Apr 27, 3:03PM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2016 after the close of trading on Tuesday, May 10, 2016. The Company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
EKSO: 4.05 (-0.02)
Buying Stocks: Investors Are Considering These on Thursday April 7
ACCESSWIRE - Thu Apr 07, 12:34PM CDT
MIAMI, FL / ACCESSWIRE / April 7, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. CANN, COOL, TTPH, and EKSO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
TTPH: 3.99 (-0.02), COOL: 3.66 (-0.08), EKSO: 4.05 (-0.02)
Bionik Acquires Synergistic, Commercial Stage Technology Portfolio
ACCESSWIRE - Mon Apr 04, 8:20AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 4, 2016 / Robotic exoskeletons have become increasingly popular in recent years. While Tony Stark popularized the concept on the big screen, several companies are diligently working to bring the technology to the real world for a number of different applications.
IBM: 160.04 (-1.32), EKSO: 4.05 (-0.02), RWLK: 6.20 (-0.05)
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
Globe Newswire - Mon Apr 04, 6:00AM CDT
RICHMOND, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with device's labeling. The Ekso GT is the first exoskeleton cleared by the FDA for use with stroke patients.
EKSO: 4.05 (-0.02)
Global Exoskeleton Robots Market 2016-2020 - Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics - Research and Markets
BusinessWire - Fri Mar 18, 8:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pz2qx6/global) has announced the addition of the "Global Exoskeleton Robots Market 2016-2020" report to their offering.
EKSO: 4.05 (-0.02), RWLK: 6.20 (-0.05)
Story Behind the Charts -- Featured Research on Progressive Care, Ekso Bionics, LVMH Moet Hennessy Louis Vuitton, and China Gold International Resources
ACCESSWIRE - Wed Mar 16, 6:55AM CDT
NEW YORK, NY / ACCESSWIRE / March 16, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Progressive Care Inc. (OTC: RXMD), Ekso Bionics Holdings Inc. (OTC: EKSO), LVMH Moet Hennessy Louis Vuitton SE (OTC: LVMUY) and China Gold International Resources Corp. Ltd. (OTC: JINFF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
EKSO: 4.05 (-0.02)
